Table 1.
1991/2 | 1992/3 | 1993/4 | 1994/5 | 1995/6 | 1996/7 | 1997/8 | 1998/9 | 1999/00 | 2000/1 | Overall % missing | 2000/1 % missing | |
Prevalent round | ||||||||||||
Women screened | 87068 | 92606 | 64287 | 39014 | 30528 | 30245 | 32385 | 31321 | 32530 | 33613 | ||
Cancers detected | 485 | 546 | 437 | 186 | 248 | 205 | 187 | 217 | 248 | 239 | ||
Invasive cancers detected | 402 | 443 | 348 | 146 | 187 | 156 | 149 | 158 | 180 | 184 | ||
Invasive cancers <10 mm | 85 | 100 | 101 | 33 | 49 | 36 | 42 | 39 | 39 | 39 | ||
Invasive cancers <15 mm | 172 | 210 | 181 | 66 | 99 | 84 | 84 | 82 | 94 | 84 | ||
Invasive cancers ≥15 mm | 213 | 205 | 134 | 77 | 83 | 70 | 63 | 71 | 83 | 96 | ||
Invasive cancers size unknown/missing | 17 | 28 | 33 | 3 | 5 | 2 | 2 | 5 | 3 | 4 | 4.3 | 2.2 |
Invasive cancers grades 1 and 2 | 274 | 284 | 213 | 106 | 135 | 123 | 119 | 124 | 153 | 142 | ||
Invasive cancers grade 3 | 58 | 61 | 40 | 15 | 30 | 28 | 22 | 25 | 23 | 40 | ||
Invasive cancers not assessable/unknown/missing | 70 | 98 | 95 | 25 | 22 | 5 | 8 | 9 | 4 | 2 | 14.4 | 1.1 |
Node negative invasive cancers | 222 | 267 | 196 | 88 | 136 | 112 | 117 | 104 | 134 | 122 | ||
Node positive invasive cancers | 108 | 89 | 64 | 44 | 38 | 41 | 30 | 39 | 41 | 54 | ||
Nodal status unknown/missing | 72 | 87 | 88 | 14 | 13 | 3 | 2 | 15 | 5 | 8 | 13.0 | 4.3 |
Incident round | ||||||||||||
Women screened | 64 | 8051 | 36133 | 56617 | 62524 | 64170 | 67127 | 66951 | 70681 | 82016 | ||
Cancers detected | 0 | 26 | 136 | 309 | 303 | 344 | 334 | 381 | 445 | 525 | ||
Invasive cancers detected | 0 | 22 | 112 | 253 | 228 | 276 | 278 | 309 | 357 | 410 | ||
Invasive cancers <10 mm | 0 | 1 | 38 | 57 | 62 | 77 | 65 | 86 | 100 | 109 | ||
Invasive cancers <15 mm | 0 | 8 | 69 | 132 | 123 | 160 | 144 | 166 | 192 | 234 | ||
Invasive cancers ≥15 mm | 0 | 14 | 42 | 116 | 98 | 114 | 131 | 139 | 160 | 168 | ||
Invasive cancers size unknown/ missing | 0 | 0 | 1 | 5 | 7 | 2 | 3 | 4 | 5 | 8 | 1.6 | 2.0 |
Invasive cancers grades 1 and 2 | 0 | 16 | 72 | 178 | 170 | 198 | 213 | 238 | 266 | 282 | ||
Invasive cancers grade 3 | 0 | 5 | 24 | 37 | 35 | 67 | 55 | 63 | 84 | 118 | ||
Invasive cancers not assessable/unknown/missing | 0 | 1 | 16 | 38 | 23 | 11 | 10 | 8 | 7 | 10 | 5.5 | 2.4 |
Node negative invasive cancers | 0 | 12 | 82 | 180 | 163 | 190 | 202 | 228 | 254 | 294 | ||
Node positive invasive cancers | 0 | 6 | 20 | 59 | 53 | 72 | 66 | 73 | 87 | 101 | ||
Nodal status unknown/missing | 0 | 4 | 10 | 14 | 12 | 14 | 10 | 8 | 16 | 15 | 4.6 | 3.7 |
Prevalent round: women attending their first invitation or those attending an appointment having previously failed to attend (ages 50–64 years). Incident round: women attending subsequent invitations having previously attended a screening appointment within the past 5 years (ages 50–64 years).